Kirby McInerney LLP Reminds UroGen Pharma Ltd. (URGN) Investors of Class Action Filing and Encourages Investors to Contact the Firm

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP reminds investors who purchased UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ:URGN) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the Company.

Source: https://www.globenewswire.com/news-release/2025/06/06/3094851/937/en/Kirby-McInerney-LLP-Reminds-UroGen-Pharma-Ltd-URGN-Investors-of-Class-Action-Filing-and-Encourages-Investors-to-Contact-the-Firm.html